State Procurement - Constitutional Violations - Prohibited
HB0334 establishes a statewide, voluntary Universal Newborn Nurse Home Visiting Program within the Maryland Department of Health. The program is intended to provide nurse home visiting services to all families with newborns residing in the state, including foster and adoptive newborns and birthing individuals within 12 weeks after delivery of a live birth or stillbirth. The bill directs the Department to design the program around evidence-based home visiting models, to work with hospitals, local health departments, community organizations, insurers, and other stakeholders, and to ensure services are available in every community. Services may be delivered in the home or virtually and must include at least one visit in the newborn’s first 12 weeks, with the option for up to three additional visits, plus follow-up contact and referrals tailored to family needs.
The bill also creates a Workgroup on Newborn Home Visiting Services to study existing programs, compare them with universal nurse home visiting models, identify service gaps and funding sources, and assess workforce needs, including cultural competency. The workgroup must report its findings to the Governor and General Assembly by December 31, 2025. In addition, the Department must collect and analyze program data, establish regulations for implementation and reimbursement, and report annually on the status of the program beginning in 2026.
HB0334 amends Maryland insurance law to require insurers, nonprofit health service plans, and health maintenance organizations to cover and reimburse the full cost of covered universal newborn nurse home visiting services. The bill generally prohibits copayments, coinsurance, and deductibles for these services, except that high-deductible health plans may apply the deductible. It also requires insurers to notify enrollees when a newborn is added to coverage and to submit claims data to the Department for monitoring purposes. The Department is authorized to adopt reimbursement methodologies such as value-based payments, capitation, or other agreed-upon approaches, and may seek a federal waiver to help finance the program.
The overall sentiment reflected in the bill text is strongly supportive of expanding maternal and infant health supports, with an emphasis on early intervention, family strengthening, and reducing disparities. Because no committee transcript or vote record was provided, there is no documented opposition or recorded vote pattern to gauge broader legislative sentiment. The structure of the bill suggests a policy consensus around evidence-based home visiting and coordinated public-private implementation, but it also anticipates operational and financing challenges by creating a workgroup and allowing flexible reimbursement methods.
Notable points of potential contention include the cost of universal statewide implementation, the mandate for insurance coverage and reimbursement, and the administrative burden of data reporting and coordination across providers. The bill also leaves important implementation details to regulation, including the definition of a community, provider selection, and reimbursement methodology. Another possible area of debate is the balance between making the program universal and keeping participation voluntary, as well as how to integrate the new program with existing home visiting and public health systems.
The bill adds a new subtitle to the Health – General Article establishing a statewide Universal Newborn Nurse Home Visiting Program and adds a new section to the Insurance Article requiring coverage and reimbursement for those services. It imposes new duties on the Maryland Department of Health to design, implement, regulate, monitor, and report on the program, and it requires insurers, nonprofit health service plans, and HMOs to cover the service subject to the bill’s terms. The bill also creates a temporary workgroup to study implementation and funding, and it authorizes the Department to seek federal financial participation through a waiver. The law applies to policies and contracts issued, delivered, or renewed on or after January 1, 2026.
The bill’s policy direction is broadly favorable toward maternal and infant health interventions, with an emphasis on universal access, evidence-based practice, and coordinated care. The text reflects a proactive, public-health-oriented approach and anticipates collaboration among state agencies, health systems, and insurers. No vote totals or committee testimony were provided, so there is no direct record of support or opposition from legislators or stakeholders in the supplied materials.
The main areas of contention are likely to be cost, insurance mandate scope, and implementation logistics. Requiring universal coverage and reimbursement could raise concerns for insurers and employers about premium impacts, while the Department and community providers may face questions about funding, staffing, and data/reporting capacity. The bill also depends on regulatory definitions and reimbursement rules that could become disputed during implementation, especially around what counts as a community, which models qualify as evidence-based, and how to coordinate overlapping home visiting services.